Calla Lily Clinical Care is in Baltimore this week for the American Society for Reproductive Medicine – ASRM 2026 Scientific Congress & Expo. 🇺🇸 Our colleague Shaun Knights is attending through 28 October. This year’s theme, Discovery, Innovation and Advancement, reflects where we are. Our first-in-human FREEDOM trial of progesterone delivered via Callavid®, our intravaginal …

It’s a great energy at the Abu Dhabi Future Health Summit this week. ☀️ The main-stage themes are prevention, longevity and the ways AI is improving health outcomes. Off the stage, one theme runs through almost every conversation I’m having: Women’s Health is a clear and growing priority across the region. 🌍 Delighted to be …

They say you need to be in the room. How about helping to lead it? On 7 October, our co-founder Dr Lara Zibners chaired the WHH Women’s Health Horizons Washington, D.C. Summit. WHH held it at the Nat’l Union Building in special partnership with the Society for Women’s Health Research (SWHR) and Women’s Health Advocates. …

Calla Lily Clinical Care has been shortlisted for Laboratory of the Year at the 2026 Lab Awards, run by Lab Innovations and Laboratory News. Past Lab Awards winners include AstraZeneca (shortlisted again this year), Thermo Scientific and the Francis Crick Institute. 🥼 All of our lab work used to be subcontracted to universities. Today we …

original article here Comment: Novel ways to deliver antibiotics By Lara Zibners17 Sep, 2026 Biotech & Pharma Editors Picks Thought Leadership Lara Zibners, paediatrician, educator, author and founder, explains why she is LEAPing for joy at Wellcome Leap’s $50 million bet on rethinking antibiotics. I spent a lot of my career in the paediatric emergency …

We held our Autumn Shareholder Reception at Calla Lily Clinical Care’s London HQ yesterday with shareholders, advisors and our team all in one room, and with a good deal to report. Approaching completion of our FREEDOM clinical trial for Callavid®. A new second use case funded by Wellcome Leap, taking our drug delivery platform into …

An inspiring visit to the Ragon Institute of Mass General Brigham, MIT, and Harvard catching up with Professor Doug Kwon and Meilin Zhu. Doug’s lab is at the front of the vaginal microbiome field: strain-level work on Lactobacillus, and more recently a Cell Host & Microbe paper on which host and microbial factors determine whether …

Our Dr Lara Zibners joins the UNC Center for the Business of Health Leadership Board. As noted by the Center: Lara is a board-certified pediatrician and pediatric emergency medicine specialist, she brings more than two decades of experience spanning clinical practice, medical education, and media, is an award-winning author, and proud alumus of UNC Kenan-Flagler …

Our co-founder Dr Lara Zibners and Dr Adam Brown of ABIG Health have published a white paper on why menopause education belongs in core medical school curriculum, not at the margins of it. 58% of medical textbooks worldwide never mention menopause. Only 31.3% of OBGYN residency programs have a menopause curriculum. Please have a read …

🇺🇲 We’ll be at the American Drug Delivery & Formulation Summit in Boston, 14–15 September. Callavid® is an intravaginal drug delivery platform, at clinical stage with progesterone delivery for threatened miscarriage and IVF support. A further development programme covers locally delivered antibiotics for UTI and AMR. Future applications include gynaecological cancers, menopause-related indications, HIV prophylaxis …